PMC:3245220 / 688-812 JSONTXT

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T451","span":{"begin":19,"end":23},"obj":"P17252"},{"id":"T452","span":{"begin":81,"end":85},"obj":"P17252"},{"id":"T453","span":{"begin":101,"end":105},"obj":"P17252"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T468","span":{"begin":26,"end":35},"obj":"Negative_regulation"},{"id":"T469","span":{"begin":26,"end":35},"obj":"Negative_regulation"},{"id":"T470","span":{"begin":45,"end":59},"obj":"Gene_expression"},{"id":"T480","span":{"begin":19,"end":23},"obj":"Protein"},{"id":"T491","span":{"begin":24,"end":25},"obj":"Protein"},{"id":"T494","span":{"begin":63,"end":85},"obj":"Protein"},{"id":"T495","span":{"begin":101,"end":111},"obj":"Protein"}],"relations":[{"id":"R411","pred":"themeOf","subj":"T480","obj":"T468"},{"id":"R415","pred":"themeOf","subj":"T491","obj":"T469"},{"id":"R417","pred":"themeOf","subj":"T494","obj":"T470"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T749","span":{"begin":19,"end":25},"obj":"Protein"},{"id":"T750","span":{"begin":63,"end":96},"obj":"Protein"},{"id":"T751","span":{"begin":101,"end":119},"obj":"Protein"},{"id":"T754","span":{"begin":45,"end":59},"obj":"Gene_expression"},{"id":"T755","span":{"begin":45,"end":59},"obj":"Gene_expression"},{"id":"T756","span":{"begin":45,"end":59},"obj":"Gene_expression"},{"id":"T757","span":{"begin":45,"end":59},"obj":"Gene_expression"}],"relations":[{"id":"R527","pred":"themeOf","subj":"T750","obj":"T756"},{"id":"R528","pred":"themeOf","subj":"T751","obj":"T757"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"events-check-again","denotations":[{"id":"T705","span":{"begin":19,"end":23},"obj":"Protein"},{"id":"T706","span":{"begin":24,"end":25},"obj":"Protein"},{"id":"T707","span":{"begin":26,"end":35},"obj":"Negative_regulation"},{"id":"T708","span":{"begin":26,"end":35},"obj":"Negative_regulation"},{"id":"T709","span":{"begin":45,"end":59},"obj":"Gene_expression"},{"id":"T710","span":{"begin":63,"end":85},"obj":"Protein"},{"id":"T711","span":{"begin":101,"end":111},"obj":"Protein"}],"relations":[{"id":"R501","pred":"themeOf","subj":"T705","obj":"T707"},{"id":"R502","pred":"themeOf","subj":"T706","obj":"T708"},{"id":"R503","pred":"themeOf","subj":"T710","obj":"T709"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"GO-MF","denotations":[{"id":"T529","span":{"begin":19,"end":23},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T530","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T531","span":{"begin":101,"end":105},"obj":"http://purl.obolibrary.org/obo/GO_0004697"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"GO-BP","denotations":[{"id":"T516","span":{"begin":19,"end":23},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T517","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T518","span":{"begin":101,"end":105},"obj":"http://purl.obolibrary.org/obo/GO_0004697"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"pmc-enju-pas","denotations":[{"id":"T347","span":{"begin":0,"end":1},"obj":"-COMMA-"},{"id":"T348","span":{"begin":2,"end":5},"obj":"DT"},{"id":"T349","span":{"begin":6,"end":18},"obj":"JJ"},{"id":"T350","span":{"begin":19,"end":25},"obj":"NN"},{"id":"T351","span":{"begin":26,"end":35},"obj":"NN"},{"id":"T352","span":{"begin":36,"end":43},"obj":"NN"},{"id":"T353","span":{"begin":43,"end":44},"obj":"-COMMA-"},{"id":"T354","span":{"begin":45,"end":59},"obj":"NN"},{"id":"T355","span":{"begin":60,"end":62},"obj":"IN"},{"id":"T356","span":{"begin":63,"end":71},"obj":"JJ"},{"id":"T357","span":{"begin":72,"end":80},"obj":"JJ"},{"id":"T358","span":{"begin":81,"end":85},"obj":"NN"},{"id":"T359","span":{"begin":86,"end":96},"obj":"NN"},{"id":"T360","span":{"begin":97,"end":100},"obj":"CC"},{"id":"T361","span":{"begin":101,"end":105},"obj":"NN"},{"id":"T362","span":{"begin":106,"end":111},"obj":"NN"},{"id":"T363","span":{"begin":112,"end":119},"obj":"VB"}],"relations":[{"id":"R313","pred":"arg2Of","subj":"T352","obj":"T347"},{"id":"R314","pred":"arg1Of","subj":"T352","obj":"T348"},{"id":"R315","pred":"arg1Of","subj":"T352","obj":"T349"},{"id":"R316","pred":"arg1Of","subj":"T352","obj":"T350"},{"id":"R317","pred":"arg1Of","subj":"T352","obj":"T351"},{"id":"R318","pred":"arg1Of","subj":"T353","obj":"T360"},{"id":"R319","pred":"arg2Of","subj":"T354","obj":"T353"},{"id":"R320","pred":"arg1Of","subj":"T354","obj":"T355"},{"id":"R321","pred":"arg2Of","subj":"T359","obj":"T355"},{"id":"R322","pred":"arg1Of","subj":"T359","obj":"T356"},{"id":"R323","pred":"arg1Of","subj":"T359","obj":"T357"},{"id":"R324","pred":"arg1Of","subj":"T359","obj":"T358"},{"id":"R325","pred":"arg1Of","subj":"T360","obj":"T363"},{"id":"R326","pred":"arg2Of","subj":"T362","obj":"T360"},{"id":"R327","pred":"arg1Of","subj":"T362","obj":"T361"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T155","span":{"begin":0,"end":1},"obj":","},{"id":"T156","span":{"begin":2,"end":5},"obj":"DT"},{"id":"T157","span":{"begin":6,"end":18},"obj":"JJ"},{"id":"T158","span":{"begin":19,"end":23},"obj":"NNP"},{"id":"T159","span":{"begin":23,"end":24},"obj":"NN"},{"id":"T160","span":{"begin":24,"end":25},"obj":"NN"},{"id":"T161","span":{"begin":26,"end":35},"obj":"NN"},{"id":"T162","span":{"begin":36,"end":43},"obj":"NNP"},{"id":"T163","span":{"begin":43,"end":44},"obj":","},{"id":"T164","span":{"begin":45,"end":59},"obj":"NN"},{"id":"T165","span":{"begin":60,"end":62},"obj":"IN"},{"id":"T166","span":{"begin":63,"end":71},"obj":"JJ"},{"id":"T167","span":{"begin":72,"end":80},"obj":"JJ"},{"id":"T168","span":{"begin":81,"end":85},"obj":"NNP"},{"id":"T169","span":{"begin":86,"end":96},"obj":"NNS"},{"id":"T170","span":{"begin":97,"end":100},"obj":"CC"},{"id":"T171","span":{"begin":101,"end":105},"obj":"NNP"},{"id":"T172","span":{"begin":106,"end":111},"obj":"NNP"},{"id":"T173","span":{"begin":112,"end":119},"obj":"VBD"}],"relations":[{"id":"R124","pred":"det","subj":"T156","obj":"T162"},{"id":"R125","pred":"amod","subj":"T157","obj":"T162"},{"id":"R126","pred":"compound","subj":"T158","obj":"T162"},{"id":"R127","pred":"compound","subj":"T159","obj":"T162"},{"id":"R128","pred":"compound","subj":"T160","obj":"T162"},{"id":"R129","pred":"compound","subj":"T161","obj":"T162"},{"id":"R131","pred":"punct","subj":"T163","obj":"T162"},{"id":"R132","pred":"appos","subj":"T164","obj":"T162"},{"id":"R133","pred":"prep","subj":"T165","obj":"T164"},{"id":"R134","pred":"amod","subj":"T166","obj":"T169"},{"id":"R135","pred":"amod","subj":"T167","obj":"T169"},{"id":"R136","pred":"compound","subj":"T168","obj":"T169"},{"id":"R137","pred":"pobj","subj":"T169","obj":"T165"},{"id":"R138","pred":"cc","subj":"T170","obj":"T169"},{"id":"R139","pred":"compound","subj":"T171","obj":"T172"},{"id":"R140","pred":"nsubj","subj":"T172","obj":"T173"},{"id":"R141","pred":"ROOT","subj":"T173","obj":"T173"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}

{"project":"test2","denotations":[{"id":"T31","span":{"begin":19,"end":23},"obj":"Protein"},{"id":"T32","span":{"begin":24,"end":25},"obj":"Protein"},{"id":"T33","span":{"begin":26,"end":35},"obj":"Negative_regulation"},{"id":"T34","span":{"begin":63,"end":85},"obj":"Protein"},{"id":"T35","span":{"begin":101,"end":111},"obj":"Protein"}],"relations":[{"id":"R18","pred":"themeOf","subj":"T31","obj":"T33"},{"id":"R19","pred":"themeOf","subj":"T32","obj":"T33"}],"text":", the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κ"}